• All Topic

    • Warning: Invalid argument supplied for foreach() in /srv/users/production/apps/events-nztech/public/wp-content/plugins/customevent/template/taxonomy-session-day.php on line 51

Day 2 - Industry Summit - 11 February

Expand All
08:30
08:50
Andrew Patterson Business Commentator
09:00

Meet and greet your fellow attendees in random breakout rooms in this icebreaker session.

09:20
Bonni Goldstein Medical Director, Canna Centers Wellness & Education
09:40
Brooke van Velden List Member, ACT Party
10:00

Research shows that being from New Zealand adds value to your brand, and that provenance matters. This session showcases the strength in brand New Zealand and  

will shed light on the value-adding opportunity for medicinal cannabis. 

  • Using New Zealand’s brand and image in the medicinal cannabis industry – how can we leverage this to increase value? 
  • Coming together and collaborating to advocate for the industry – what is the opportunity here? 
  • A view into the practical tools that the New Zealand Story group have to help 
David Downs Chief Executive Officer, New Zealand Story
10:40
11:00
  • The opportunity to develop the CBD sector in New Zealand – what are the resources available to achieve this?
  • Insights into the economic opportunity
Mitch Cuevas Pharmaceutical Director, Eqalis
11:40
  • Explaining the work currently being undertaken by Crown Research Institutes in the medicinal cannabis space
  • Advocating for the industry – a spotlight on the work taking place here

Dr Richard Newcomb, PhD Chief Scientist, Plant & Food Research
Dr Emma Bermingham Science Objective Leader Added Value Foods & Bio-based Products, AgResearch
Dr Florian Graichen GM - Forests to Biobased products, Scion
12:10

Mark Robinson, Business Innovation Advisor – Health Sector, Callaghan Innovation

12:30
13:00
  • Application process in obtaining a licence through the Medicinal Cannabis Agency – tips and tricks
    Facilitator: Andrea Eng, Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health
  • EBM4CBD/THC
    Facilitators: Dr Michael Murphy MB, BS, Pharm B.Sc (Hons), Clinical Director, CannaPlus+;
    Dr Afraz Adam MBBS. FRNZCUC, Chief Medical Officer, CannaPlus+
    Extraction technologies
    Steve Tallon Team Leader, Process Engineering Group, Callaghan Innovation
  • Analysis and testing
    Facilitators: Bruce Fraser, New Zealand General Manager, Shimadzu
    Sam Dallas, Analytical Technology Technician, Hill Laboratories
14:20
14:40

  • The endocannabinoid system in animals
  • A brief history of veterinary medicinal cannabis
  • Toxicology and the THC myth
  • Local and overseas clinical trials to date
  • Market opportunities and regulatory affairs
Jacob Morrison
15:10
Martin A Lee Director, Project CBD
15:40
13:00
Andrea Eng Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health
13:00
Dr Michael Murphy Clinical Director, CannaPlus+
Dr Afraz Adam MBBS. FRNZCUC Chief Medical Officer, CannaPlus+
13:00
Steve Tallon Team Leader, Process Engineering Group, Callaghan Innovation
13:00
Bruce Fraser Team Leader, Process Engineering Group, Callaghan Innovation
Sam Dallas Analytical Technology Technician, Hill Laboratories
13:40
Andrea Eng Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health
13:40
Dr Afraz Adam MBBS. FRNZCUC Chief Medical Officer, CannaPlus+
Dr. Michael Murphy MB, BS, Pharm B.Sc (Hons) Clinical Director, CannaPlus+
13:40
Steve Tallon Team Leader, Process Engineering Group, Callaghan Innovation
13:40
Bruce Fraser Team Leader, Process Engineering Group, Callaghan Innovation
Sam Dallas Analytical Technology Technician, Hill Laboratories